Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0100 Transporter Info | ||||
| Gene Name | SLC16A1 | ||||
| Protein Name | Monocarboxylate transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs1049434 | ||||
| Site of GPD | chr1:112913924 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>T | ||||
| Minor Allele Frequency | A=0.3233/1619 (Global) | ||||
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| N.A. | N.A. | Multiple myeloma | Correlated with the progression-free and overall survival in patients (compare with allele A) | [ 1] | |
| Genetic Polymorphism | rs7169 | ||||
| Site of GPD | chr1:112912477 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>A | ||||
| Minor Allele Frequency | G=0.3210/635 (Global) | ||||
| Genotype GG | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Valproic Acid | N.A. | Hypertension | Genotype GG is associated with increased clinical benefit to valproic acid in children with Epilepsy as compared to genotypes AA + AG. | [ 2] | |
| References | |||||
| 1 | Genetic variations in the monocarboxylate transporter genes (SLC16A1, SLC16A3, and SLC16A11) in the Japanese population. Drug Metab Pharmacokinet. 2018 Oct;33(5):215-218. | ||||
| 2 | Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients. Per Med. 2025 Feb;22(1):11-19. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.